Morphine, Hydromorphone and 6-MAM in Plasma Analyzed with LCMS - AppNote
July 11, 2014
/
/
/
/
Morphine, Hydromorphone and 6-Monoacetylmorphine
(
6-MAM) in Plasma
Column: Cogent Bidentate C18 2.o™, 2.2 μm, 120 Å
Catalog No.: 40218-05P-2
Dimensions: 2.1 x 50 mm
Mobile Phase:
-- A: DI Water / 0.1% Formic Acid (v/v)
-- B: 50:50 Acetonitrile / Methanol / 0.1% Formic Acid (v/v)
Gradient:
Post Time: 3 minutes
Injection vol.: 1 μL
Flow rate: 0.4 mL / minute
Detection: ESI – POS - Agilent 6210 MSD TOF Mass Spectrometer
Sample Preparation: To a spiked Plasma Sample (1 mL), 1 mL of an Ammonia solution (0.1% v/v) was added and vortex-mixed for 30 seconds to alkalize the Plasma. Then, the alkalized Plasma Sample was extracted with two 4 mL Ethyl Acetate aliquots by vortex for 5 minutes, and centrifuged at 4000 rpm for 8 minutes at room temperature. The supernatant was separated and evaporated to dryness under a gentle stream of Nitrogen. The residue was reconstituted with 200 µL Mobile Phase, and a 1 µL aliquot of the reconstituted solution was injected into the LC– ESI-MS for analysis.
Note : Morphine is used as an analgesic drug in the treatment of the severe pain. Hydromorphone, a semi-synthetic derivative of Morphine is used in cases of Morphine-resistant Cancer-related pain and 6-Monoacetylmorphine (6-MAM) is a specific indicator for Heroin use. All three drugs remain the selected substances in monitoring of drug abuse and addiction. Heroin use remains a serious public health issue which accounts for a substantial proportion of the health costs. Analysis of Plasma Samples for the presence of the three substances is essential in assessing short or long term exposure to the drugs.
Attachment No 310 Morphine, Hydromorphone and 6-MAM in Plasma Analyzed with LCMS pdf 0.2 Mb Download File
This AppNote presents a Method that could be used for a routine analysis of Plasma Samples or (whole blood samples after changing the extraction procedure) for the presence of Morphine, Hydromorphone (isobaric compounds) or 6-MAM (an indicator of Heroin use).
Peaks:
1. Morphine
286.1438 m/z [M+H]+
2. Hydromorphone
286.1438 m/z [M+H]+
3. 6-Monoacetylmorphine (6-MAM)
328.1543 m/z [M+H]+
Column: Cogent Bidentate C18 2.o™, 2.2 μm, 120 Å
Catalog No.: 40218-05P-2
Dimensions: 2.1 x 50 mm
Mobile Phase:
-- A: DI Water / 0.1% Formic Acid (v/v)
-- B: 50:50 Acetonitrile / Methanol / 0.1% Formic Acid (v/v)
Gradient:
| Time (minutes) | %B |
|---|---|
| 0 | 5 |
| 4 | 50 |
| 5 | 90 |
| 6 | 90 |
| 7 | 5 |
Post Time: 3 minutes
Injection vol.: 1 μL
Flow rate: 0.4 mL / minute
Detection: ESI – POS - Agilent 6210 MSD TOF Mass Spectrometer
Sample Preparation: To a spiked Plasma Sample (1 mL), 1 mL of an Ammonia solution (0.1% v/v) was added and vortex-mixed for 30 seconds to alkalize the Plasma. Then, the alkalized Plasma Sample was extracted with two 4 mL Ethyl Acetate aliquots by vortex for 5 minutes, and centrifuged at 4000 rpm for 8 minutes at room temperature. The supernatant was separated and evaporated to dryness under a gentle stream of Nitrogen. The residue was reconstituted with 200 µL Mobile Phase, and a 1 µL aliquot of the reconstituted solution was injected into the LC– ESI-MS for analysis.
Note : Morphine is used as an analgesic drug in the treatment of the severe pain. Hydromorphone, a semi-synthetic derivative of Morphine is used in cases of Morphine-resistant Cancer-related pain and 6-Monoacetylmorphine (6-MAM) is a specific indicator for Heroin use. All three drugs remain the selected substances in monitoring of drug abuse and addiction. Heroin use remains a serious public health issue which accounts for a substantial proportion of the health costs. Analysis of Plasma Samples for the presence of the three substances is essential in assessing short or long term exposure to the drugs.
Attachment No 310 Morphine, Hydromorphone and 6-MAM in Plasma Analyzed with LCMS pdf 0.2 Mb Download File